Northwest Biotherapeutics Inc (NWBO) Institutional Ownership

Ownership Summary

The institutional landscape for Northwest Biotherapeutics Inc (OTC:NWBO) includes 4 filers as of the latest reporting cycle ending December 2025.

• Institutional ownership in Northwest Biotherapeutics edged down to 0.0% in December 2025, compared to 0.0% in September 2025.
• In percentage terms, this reflects as a holdings change of 3.10% quarter on quarter, and a decrease of 55.56% year over year.
• During the quarter, 1 institutions bought more Northwest Biotherapeutics shares, 0 sold shares, and 3 of the 4 total investors held their position steady.
• The total number of shares held by institutions in Northwest Biotherapeutics increased to 99.77K as of December 2025, a net change of up by 3.00K shares quarter on quarter, and down 115.11K shares year over year.
• With 60.15K shares, Opus Capital Group, LLC commands the largest institutional position in Northwest Biotherapeutics as of December 31, 2025, equating to 0.00% of the company.
• Among the most significant buyers of Northwest Biotherapeutics during December 2025 were Ethos Financial Group, LLC (3.00K).
• The top 4 institutional holders of Northwest Biotherapeutics for the quarter ending December 2025 included Opus Capital Group, LLC (60.15K), Ethos Financial Group, LLC (28.35K), ADVISORS MANAGEMENT GROUP INC /ADV (10.27K), Coston, McIsaac & Partners (1.00K).